ORIGIN Scientia is our biomedical arm, specialising in insects-based innovation and R&D; the deriving beneficial ingredients and solutions from the ecology of insects. The company’s core activities are in Manufacturing and Supplying of Bio-medical products, and Clinical Services and Research & Development to better wound care standards and practices for the medical community and society in Singapore and the region.
The most recent developmental product under ORIGIN Scientia is MediFly.
Medifly is the product brand name for sterile, hospital grade maggots, used in maggot debridement therapy under the name of ‘BioDressings’.
These maggots are produced under laboratory conditions and are sterile to ensure the safety of the product when used. A predetermined number of maggots are packaged in either a vial form, or a bag, and these maggots are subsequently placed directly onto the patients’ wound for the removal of necrotic tissues or slough in the wound beds.
Maggot Debridement Therapy is a non-aggressive form of slough/necrotic tissue removal. When MDT is carried out with the use of ORIGIN Scientia’s MediFly, the slough/necrotic tissueis removed by either direct ingestation of the maggots on the wound or by softening of the slough/necrotic tissue by maggot oral secretions. This form of wound debridement has been proven to be a cost effective solution in chronic wound debridement.